Health Care & Life Sciences » Pharmaceuticals | Kindred Biosciences Inc.

Kindred Biosciences Inc. | Ownership

Companies that own Kindred Biosciences Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Park West Asset Management LLC
6,002,053
17.76%
845,262
3.61%
06/30/2018
Ariel Investments LLC
2,218,612
6.56%
456,783
0.33%
06/30/2018
Morgan Stanley & Co. LLC
2,157,047
6.38%
-5,124
0.04%
06/30/2018
Dimensional Fund Advisors LP
1,345,972
3.98%
-19,030
0.01%
06/30/2018
The Vanguard Group, Inc.
1,279,623
3.79%
186,186
0%
06/30/2018
BlackRock Fund Advisors
1,137,991
3.37%
140,176
0%
06/30/2018
Adage Capital Management LP
975,000
2.89%
975,000
0.03%
06/30/2018
Renaissance Technologies LLC
948,700
2.81%
253,500
0.02%
06/30/2018
General American Investors Co., Inc. (Investment Management)
594,878
1.76%
-3,881
0.68%
06/30/2018
Pacific View Asset Management LLC
545,000
1.61%
55,000
5.73%
06/30/2018

About Kindred Biosciences

View Profile
Address
1555 Bayshore Highway
Burlingame California 94010
United States
Employees -
Website http://www.kindredbio.com
Updated 07/08/2019
Kindred Biosciences, Inc. is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. The company was founded by Richard Chin and Denise M. Bevers on September 25, 2012 and is headquartered in Burlingame, CA.